Steven Sell

Steven Sell is a declared insider at 2 companies (chief executive); the most frequent names are Health Net Inc and Agilon Health, Inc. Between 18 December 2009 and 15 April 2025, the trades on record add up to 86 filings.

Market trades split into 4 purchases (€563k) and 20 sales (€9.1M). No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 46 share grants and 11 option exercises. Since January 2025: 1 purchase and no sales on the market.

Half of the purchases are above €61k and half below. The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month.

Most recently, on 16 April 2025, the filings show a share grant worth €110k in Agilon Health, Inc. The latest purchase dates back some time: it was published 585 days ago, on 18 March 2025. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.